nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—CACNA2D2—neck—thyroid cancer	0.0199	0.136	CbGeAlD
Gabapentin—BCAT1—trachea—thyroid cancer	0.0131	0.089	CbGeAlD
Gabapentin—CACNA1B—head—thyroid cancer	0.0117	0.0794	CbGeAlD
Gabapentin—ADORA1—saliva-secreting gland—thyroid cancer	0.0108	0.0734	CbGeAlD
Gabapentin—BCAT1—thyroid gland—thyroid cancer	0.0103	0.0704	CbGeAlD
Gabapentin—CACNA2D2—thyroid gland—thyroid cancer	0.00947	0.0645	CbGeAlD
Gabapentin—BCAT1—head—thyroid cancer	0.00917	0.0624	CbGeAlD
Gabapentin—CACNA2D2—head—thyroid cancer	0.00841	0.0573	CbGeAlD
Gabapentin—CACNA1B—lymph node—thyroid cancer	0.00816	0.0556	CbGeAlD
Gabapentin—CACNA2D1—thyroid gland—thyroid cancer	0.00681	0.0464	CbGeAlD
Gabapentin—ADORA1—thyroid gland—thyroid cancer	0.00657	0.0448	CbGeAlD
Gabapentin—BCAT1—lymph node—thyroid cancer	0.00642	0.0437	CbGeAlD
Gabapentin—CACNA2D1—head—thyroid cancer	0.00605	0.0412	CbGeAlD
Gabapentin—CACNA2D2—lymph node—thyroid cancer	0.00589	0.0401	CbGeAlD
Gabapentin—ADORA1—head—thyroid cancer	0.00583	0.0397	CbGeAlD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.00511	0.123	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.00451	0.109	CbGpPWpGaD
Gabapentin—CACNA2D1—lymph node—thyroid cancer	0.00423	0.0288	CbGeAlD
Gabapentin—ADORA1—lymph node—thyroid cancer	0.00408	0.0278	CbGeAlD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.00285	0.0688	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.00252	0.0607	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00199	0.048	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—PRKAR1A—thyroid cancer	0.00177	0.0427	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TERT—thyroid cancer	0.00159	0.0385	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.00156	0.0377	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.00122	0.0295	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NKX2-1—thyroid cancer	0.00103	0.0249	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MINPP1—thyroid cancer	0.00081	0.0195	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CALCB—thyroid cancer	0.000768	0.0185	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NDUFA13—thyroid cancer	0.000689	0.0166	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CHST14—thyroid cancer	0.000647	0.0156	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TP53—thyroid cancer	0.000607	0.0147	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000549	0.0133	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HPGD—thyroid cancer	0.000522	0.0126	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MINPP1—thyroid cancer	0.000491	0.0118	CbGpPWpGaD
Gabapentin—Muscular weakness—Epirubicin—thyroid cancer	0.000475	0.000586	CcSEcCtD
Gabapentin—Cardiac arrest—Doxorubicin—thyroid cancer	0.000474	0.000584	CcSEcCtD
Gabapentin—Dizziness—Sorafenib—thyroid cancer	0.000474	0.000584	CcSEcCtD
Gabapentin—Mood swings—Doxorubicin—thyroid cancer	0.000472	0.000582	CcSEcCtD
Gabapentin—Ataxia—Doxorubicin—thyroid cancer	0.000469	0.000578	CcSEcCtD
Gabapentin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000467	0.000576	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000467	0.0113	CbGpPWpGaD
Gabapentin—Influenza—Epirubicin—thyroid cancer	0.000466	0.000574	CcSEcCtD
Gabapentin—Asthma—Epirubicin—thyroid cancer	0.000466	0.000574	CcSEcCtD
Gabapentin—Dysphagia—Epirubicin—thyroid cancer	0.000466	0.000574	CcSEcCtD
Gabapentin—Dehydration—Doxorubicin—thyroid cancer	0.000464	0.000571	CcSEcCtD
Gabapentin—Eosinophilia—Epirubicin—thyroid cancer	0.000461	0.000568	CcSEcCtD
Gabapentin—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00046	0.000567	CcSEcCtD
Gabapentin—Dry skin—Doxorubicin—thyroid cancer	0.000457	0.000563	CcSEcCtD
Gabapentin—Pancreatitis—Epirubicin—thyroid cancer	0.000457	0.000563	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—SST—thyroid cancer	0.000457	0.011	CbGpPWpGaD
Gabapentin—Vomiting—Sorafenib—thyroid cancer	0.000456	0.000561	CcSEcCtD
Gabapentin—Angina pectoris—Epirubicin—thyroid cancer	0.000454	0.000559	CcSEcCtD
Gabapentin—Rash—Sorafenib—thyroid cancer	0.000452	0.000557	CcSEcCtD
Gabapentin—Dermatitis—Sorafenib—thyroid cancer	0.000452	0.000556	CcSEcCtD
Gabapentin—Breast disorder—Doxorubicin—thyroid cancer	0.000451	0.000555	CcSEcCtD
Gabapentin—Headache—Sorafenib—thyroid cancer	0.000449	0.000553	CcSEcCtD
Gabapentin—Bronchitis—Epirubicin—thyroid cancer	0.000448	0.000552	CcSEcCtD
Gabapentin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000446	0.000549	CcSEcCtD
Gabapentin—Gastritis—Doxorubicin—thyroid cancer	0.000441	0.000544	CcSEcCtD
Gabapentin—Muscular weakness—Doxorubicin—thyroid cancer	0.00044	0.000542	CcSEcCtD
Gabapentin—Dysuria—Epirubicin—thyroid cancer	0.000436	0.000537	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CALCB—thyroid cancer	0.000434	0.0105	CbGpPWpGaD
Gabapentin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000433	0.000533	CcSEcCtD
Gabapentin—Dysphagia—Doxorubicin—thyroid cancer	0.000431	0.000531	CcSEcCtD
Gabapentin—Influenza—Doxorubicin—thyroid cancer	0.000431	0.000531	CcSEcCtD
Gabapentin—Asthma—Doxorubicin—thyroid cancer	0.000431	0.000531	CcSEcCtD
Gabapentin—Pollakiuria—Epirubicin—thyroid cancer	0.00043	0.00053	CcSEcCtD
Gabapentin—Eosinophilia—Doxorubicin—thyroid cancer	0.000427	0.000526	CcSEcCtD
Gabapentin—Nausea—Sorafenib—thyroid cancer	0.000426	0.000525	CcSEcCtD
Gabapentin—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000425	0.000524	CcSEcCtD
Gabapentin—Weight increased—Epirubicin—thyroid cancer	0.000424	0.000522	CcSEcCtD
Gabapentin—Pancreatitis—Doxorubicin—thyroid cancer	0.000423	0.000521	CcSEcCtD
Gabapentin—Weight decreased—Epirubicin—thyroid cancer	0.000421	0.000519	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—BRAF—thyroid cancer	0.000421	0.0102	CbGpPWpGaD
Gabapentin—Hyperglycaemia—Epirubicin—thyroid cancer	0.00042	0.000518	CcSEcCtD
Gabapentin—Angina pectoris—Doxorubicin—thyroid cancer	0.00042	0.000517	CcSEcCtD
Gabapentin—Pneumonia—Epirubicin—thyroid cancer	0.000418	0.000515	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—NDUFA13—thyroid cancer	0.000417	0.0101	CbGpPWpGaD
Gabapentin—Infestation—Epirubicin—thyroid cancer	0.000415	0.000512	CcSEcCtD
Gabapentin—Drowsiness—Epirubicin—thyroid cancer	0.000415	0.000512	CcSEcCtD
Gabapentin—Infestation NOS—Epirubicin—thyroid cancer	0.000415	0.000512	CcSEcCtD
Gabapentin—Bronchitis—Doxorubicin—thyroid cancer	0.000415	0.000511	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000412	0.000507	CcSEcCtD
Gabapentin—Renal failure—Epirubicin—thyroid cancer	0.000408	0.000503	CcSEcCtD
Gabapentin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000407	0.000502	CcSEcCtD
Gabapentin—Jaundice—Epirubicin—thyroid cancer	0.000405	0.000499	CcSEcCtD
Gabapentin—Stomatitis—Epirubicin—thyroid cancer	0.000405	0.000499	CcSEcCtD
Gabapentin—Urinary tract infection—Epirubicin—thyroid cancer	0.000404	0.000497	CcSEcCtD
Gabapentin—Conjunctivitis—Epirubicin—thyroid cancer	0.000404	0.000497	CcSEcCtD
Gabapentin—Dysuria—Doxorubicin—thyroid cancer	0.000403	0.000497	CcSEcCtD
Gabapentin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000401	0.000494	CcSEcCtD
Gabapentin—Sweating—Epirubicin—thyroid cancer	0.000398	0.000491	CcSEcCtD
Gabapentin—Pollakiuria—Doxorubicin—thyroid cancer	0.000398	0.000491	CcSEcCtD
Gabapentin—Haematuria—Epirubicin—thyroid cancer	0.000396	0.000488	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CALCB—thyroid cancer	0.000394	0.00951	CbGpPWpGaD
Gabapentin—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000393	0.000485	CcSEcCtD
Gabapentin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000393	0.000484	CcSEcCtD
Gabapentin—Weight increased—Doxorubicin—thyroid cancer	0.000392	0.000483	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CHST14—thyroid cancer	0.000392	0.00947	CbGpPWpGaD
Gabapentin—Epistaxis—Epirubicin—thyroid cancer	0.000392	0.000483	CcSEcCtD
Gabapentin—Weight decreased—Doxorubicin—thyroid cancer	0.00039	0.00048	CcSEcCtD
Gabapentin—Sinusitis—Epirubicin—thyroid cancer	0.00039	0.00048	CcSEcCtD
Gabapentin—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000389	0.000479	CcSEcCtD
Gabapentin—Pneumonia—Doxorubicin—thyroid cancer	0.000387	0.000476	CcSEcCtD
Gabapentin—Infestation—Doxorubicin—thyroid cancer	0.000384	0.000473	CcSEcCtD
Gabapentin—Infestation NOS—Doxorubicin—thyroid cancer	0.000384	0.000473	CcSEcCtD
Gabapentin—Drowsiness—Doxorubicin—thyroid cancer	0.000384	0.000473	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000381	0.000469	CcSEcCtD
Gabapentin—Bradycardia—Epirubicin—thyroid cancer	0.00038	0.000468	CcSEcCtD
Gabapentin—Renal failure—Doxorubicin—thyroid cancer	0.000378	0.000465	CcSEcCtD
Gabapentin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000377	0.000464	CcSEcCtD
Gabapentin—Stomatitis—Doxorubicin—thyroid cancer	0.000375	0.000462	CcSEcCtD
Gabapentin—Jaundice—Doxorubicin—thyroid cancer	0.000375	0.000462	CcSEcCtD
Gabapentin—Rhinitis—Epirubicin—thyroid cancer	0.000374	0.000461	CcSEcCtD
Gabapentin—Urinary tract infection—Doxorubicin—thyroid cancer	0.000374	0.00046	CcSEcCtD
Gabapentin—Conjunctivitis—Doxorubicin—thyroid cancer	0.000374	0.00046	CcSEcCtD
Gabapentin—Haemorrhage—Epirubicin—thyroid cancer	0.000373	0.000459	CcSEcCtD
Gabapentin—Hepatitis—Epirubicin—thyroid cancer	0.000373	0.000459	CcSEcCtD
Gabapentin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000371	0.000457	CcSEcCtD
Gabapentin—Pharyngitis—Epirubicin—thyroid cancer	0.00037	0.000456	CcSEcCtD
Gabapentin—Sweating—Doxorubicin—thyroid cancer	0.000368	0.000454	CcSEcCtD
Gabapentin—Urinary tract disorder—Epirubicin—thyroid cancer	0.000368	0.000454	CcSEcCtD
Gabapentin—Oedema peripheral—Epirubicin—thyroid cancer	0.000367	0.000453	CcSEcCtD
Gabapentin—Haematuria—Doxorubicin—thyroid cancer	0.000366	0.000451	CcSEcCtD
Gabapentin—Connective tissue disorder—Epirubicin—thyroid cancer	0.000366	0.000451	CcSEcCtD
Gabapentin—Urethral disorder—Epirubicin—thyroid cancer	0.000366	0.00045	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000364	0.00879	CbGpPWpGaD
Gabapentin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000364	0.000448	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000363	0.00876	CbGpPWpGaD
Gabapentin—Epistaxis—Doxorubicin—thyroid cancer	0.000363	0.000447	CcSEcCtD
Gabapentin—Sinusitis—Doxorubicin—thyroid cancer	0.000361	0.000444	CcSEcCtD
Gabapentin—Visual impairment—Epirubicin—thyroid cancer	0.000359	0.000443	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—TSHR—thyroid cancer	0.000355	0.00858	CbGpPWpGaD
Gabapentin—Erythema multiforme—Epirubicin—thyroid cancer	0.000353	0.000434	CcSEcCtD
Gabapentin—Bradycardia—Doxorubicin—thyroid cancer	0.000351	0.000433	CcSEcCtD
Gabapentin—Eye disorder—Epirubicin—thyroid cancer	0.000348	0.000429	CcSEcCtD
Gabapentin—Tinnitus—Epirubicin—thyroid cancer	0.000348	0.000428	CcSEcCtD
Gabapentin—Cardiac disorder—Epirubicin—thyroid cancer	0.000346	0.000426	CcSEcCtD
Gabapentin—Rhinitis—Doxorubicin—thyroid cancer	0.000346	0.000426	CcSEcCtD
Gabapentin—Haemorrhage—Doxorubicin—thyroid cancer	0.000345	0.000425	CcSEcCtD
Gabapentin—Hepatitis—Doxorubicin—thyroid cancer	0.000345	0.000425	CcSEcCtD
Gabapentin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000343	0.000423	CcSEcCtD
Gabapentin—Pharyngitis—Doxorubicin—thyroid cancer	0.000342	0.000422	CcSEcCtD
Gabapentin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000341	0.00042	CcSEcCtD
Gabapentin—Oedema peripheral—Doxorubicin—thyroid cancer	0.00034	0.000419	CcSEcCtD
Gabapentin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000339	0.000418	CcSEcCtD
Gabapentin—Urethral disorder—Doxorubicin—thyroid cancer	0.000338	0.000417	CcSEcCtD
Gabapentin—Immune system disorder—Epirubicin—thyroid cancer	0.000337	0.000415	CcSEcCtD
Gabapentin—Mediastinal disorder—Epirubicin—thyroid cancer	0.000336	0.000414	CcSEcCtD
Gabapentin—Chills—Epirubicin—thyroid cancer	0.000335	0.000412	CcSEcCtD
Gabapentin—Visual impairment—Doxorubicin—thyroid cancer	0.000333	0.00041	CcSEcCtD
Gabapentin—Alopecia—Epirubicin—thyroid cancer	0.00033	0.000406	CcSEcCtD
Gabapentin—Mental disorder—Epirubicin—thyroid cancer	0.000327	0.000402	CcSEcCtD
Gabapentin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000326	0.000402	CcSEcCtD
Gabapentin—Erythema—Epirubicin—thyroid cancer	0.000325	0.0004	CcSEcCtD
Gabapentin—Malnutrition—Epirubicin—thyroid cancer	0.000325	0.0004	CcSEcCtD
Gabapentin—Eye disorder—Doxorubicin—thyroid cancer	0.000322	0.000397	CcSEcCtD
Gabapentin—Tinnitus—Doxorubicin—thyroid cancer	0.000322	0.000396	CcSEcCtD
Gabapentin—Cardiac disorder—Doxorubicin—thyroid cancer	0.00032	0.000394	CcSEcCtD
Gabapentin—Flatulence—Epirubicin—thyroid cancer	0.00032	0.000394	CcSEcCtD
Gabapentin—Tension—Epirubicin—thyroid cancer	0.000319	0.000392	CcSEcCtD
Gabapentin—Dysgeusia—Epirubicin—thyroid cancer	0.000318	0.000392	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—HPGD—thyroid cancer	0.000316	0.00763	CbGpPWpGaD
Gabapentin—Nervousness—Epirubicin—thyroid cancer	0.000315	0.000388	CcSEcCtD
Gabapentin—Back pain—Epirubicin—thyroid cancer	0.000314	0.000387	CcSEcCtD
Gabapentin—Muscle spasms—Epirubicin—thyroid cancer	0.000312	0.000384	CcSEcCtD
Gabapentin—Immune system disorder—Doxorubicin—thyroid cancer	0.000312	0.000384	CcSEcCtD
Gabapentin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000311	0.000383	CcSEcCtD
Gabapentin—Chills—Doxorubicin—thyroid cancer	0.00031	0.000381	CcSEcCtD
Gabapentin—Vision blurred—Epirubicin—thyroid cancer	0.000306	0.000377	CcSEcCtD
Gabapentin—Alopecia—Doxorubicin—thyroid cancer	0.000305	0.000376	CcSEcCtD
Gabapentin—Mental disorder—Doxorubicin—thyroid cancer	0.000302	0.000372	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—PTCH1—thyroid cancer	0.000302	0.0073	CbGpPWpGaD
Gabapentin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000301	0.000371	CcSEcCtD
Gabapentin—Malnutrition—Doxorubicin—thyroid cancer	0.0003	0.00037	CcSEcCtD
Gabapentin—Erythema—Doxorubicin—thyroid cancer	0.0003	0.00037	CcSEcCtD
Gabapentin—Anaemia—Epirubicin—thyroid cancer	0.0003	0.00037	CcSEcCtD
Gabapentin—BCAT1—Metabolism—TPR—thyroid cancer	0.0003	0.00723	CbGpPWpGaD
Gabapentin—Agitation—Epirubicin—thyroid cancer	0.000298	0.000367	CcSEcCtD
Gabapentin—Flatulence—Doxorubicin—thyroid cancer	0.000296	0.000365	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PRKAR1A—thyroid cancer	0.000295	0.00712	CbGpPWpGaD
Gabapentin—Tension—Doxorubicin—thyroid cancer	0.000295	0.000363	CcSEcCtD
Gabapentin—Dysgeusia—Doxorubicin—thyroid cancer	0.000294	0.000362	CcSEcCtD
Gabapentin—Malaise—Epirubicin—thyroid cancer	0.000293	0.000361	CcSEcCtD
Gabapentin—Nervousness—Doxorubicin—thyroid cancer	0.000292	0.000359	CcSEcCtD
Gabapentin—Vertigo—Epirubicin—thyroid cancer	0.000292	0.000359	CcSEcCtD
Gabapentin—Syncope—Epirubicin—thyroid cancer	0.000291	0.000359	CcSEcCtD
Gabapentin—Leukopenia—Epirubicin—thyroid cancer	0.000291	0.000358	CcSEcCtD
Gabapentin—Back pain—Doxorubicin—thyroid cancer	0.000291	0.000358	CcSEcCtD
Gabapentin—Muscle spasms—Doxorubicin—thyroid cancer	0.000289	0.000356	CcSEcCtD
Gabapentin—Palpitations—Epirubicin—thyroid cancer	0.000287	0.000353	CcSEcCtD
Gabapentin—Loss of consciousness—Epirubicin—thyroid cancer	0.000285	0.000351	CcSEcCtD
Gabapentin—Cough—Epirubicin—thyroid cancer	0.000283	0.000349	CcSEcCtD
Gabapentin—Vision blurred—Doxorubicin—thyroid cancer	0.000283	0.000349	CcSEcCtD
Gabapentin—Convulsion—Epirubicin—thyroid cancer	0.000281	0.000346	CcSEcCtD
Gabapentin—Hypertension—Epirubicin—thyroid cancer	0.00028	0.000345	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—BRAF—thyroid cancer	0.000279	0.00673	CbGpPWpGaD
Gabapentin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000279	0.000343	CcSEcCtD
Gabapentin—Anaemia—Doxorubicin—thyroid cancer	0.000278	0.000342	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—SST—thyroid cancer	0.000276	0.00667	CbGpPWpGaD
Gabapentin—Myalgia—Epirubicin—thyroid cancer	0.000276	0.00034	CcSEcCtD
Gabapentin—Arthralgia—Epirubicin—thyroid cancer	0.000276	0.00034	CcSEcCtD
Gabapentin—Chest pain—Epirubicin—thyroid cancer	0.000276	0.00034	CcSEcCtD
Gabapentin—Agitation—Doxorubicin—thyroid cancer	0.000276	0.00034	CcSEcCtD
Gabapentin—Anxiety—Epirubicin—thyroid cancer	0.000275	0.000339	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000274	0.000338	CcSEcCtD
Gabapentin—Discomfort—Epirubicin—thyroid cancer	0.000273	0.000336	CcSEcCtD
Gabapentin—Malaise—Doxorubicin—thyroid cancer	0.000271	0.000334	CcSEcCtD
Gabapentin—Dry mouth—Epirubicin—thyroid cancer	0.00027	0.000333	CcSEcCtD
Gabapentin—Vertigo—Doxorubicin—thyroid cancer	0.00027	0.000332	CcSEcCtD
Gabapentin—Syncope—Doxorubicin—thyroid cancer	0.000269	0.000332	CcSEcCtD
Gabapentin—Leukopenia—Doxorubicin—thyroid cancer	0.000269	0.000331	CcSEcCtD
Gabapentin—Confusional state—Epirubicin—thyroid cancer	0.000267	0.000329	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—CALCA—thyroid cancer	0.000266	0.00642	CbGpPWpGaD
Gabapentin—Palpitations—Doxorubicin—thyroid cancer	0.000265	0.000327	CcSEcCtD
Gabapentin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000265	0.000326	CcSEcCtD
Gabapentin—Oedema—Epirubicin—thyroid cancer	0.000265	0.000326	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—PPARG—thyroid cancer	0.000264	0.00638	CbGpPWpGaD
Gabapentin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000264	0.000325	CcSEcCtD
Gabapentin—Infection—Epirubicin—thyroid cancer	0.000263	0.000324	CcSEcCtD
Gabapentin—Cough—Doxorubicin—thyroid cancer	0.000262	0.000323	CcSEcCtD
Gabapentin—Shock—Epirubicin—thyroid cancer	0.000261	0.000321	CcSEcCtD
Gabapentin—Convulsion—Doxorubicin—thyroid cancer	0.00026	0.000321	CcSEcCtD
Gabapentin—Nervous system disorder—Epirubicin—thyroid cancer	0.00026	0.00032	CcSEcCtD
Gabapentin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000259	0.00032	CcSEcCtD
Gabapentin—Hypertension—Doxorubicin—thyroid cancer	0.000259	0.000319	CcSEcCtD
Gabapentin—Tachycardia—Epirubicin—thyroid cancer	0.000259	0.000319	CcSEcCtD
Gabapentin—Skin disorder—Epirubicin—thyroid cancer	0.000257	0.000317	CcSEcCtD
Gabapentin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000256	0.000316	CcSEcCtD
Gabapentin—Myalgia—Doxorubicin—thyroid cancer	0.000256	0.000315	CcSEcCtD
Gabapentin—Chest pain—Doxorubicin—thyroid cancer	0.000256	0.000315	CcSEcCtD
Gabapentin—Arthralgia—Doxorubicin—thyroid cancer	0.000256	0.000315	CcSEcCtD
Gabapentin—Anxiety—Doxorubicin—thyroid cancer	0.000255	0.000314	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000254	0.000313	CcSEcCtD
Gabapentin—Discomfort—Doxorubicin—thyroid cancer	0.000253	0.000311	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000253	0.0061	CbGpPWpGaD
Gabapentin—Anorexia—Epirubicin—thyroid cancer	0.000253	0.000311	CcSEcCtD
Gabapentin—Dry mouth—Doxorubicin—thyroid cancer	0.00025	0.000308	CcSEcCtD
Gabapentin—Hypotension—Epirubicin—thyroid cancer	0.000248	0.000305	CcSEcCtD
Gabapentin—Confusional state—Doxorubicin—thyroid cancer	0.000247	0.000304	CcSEcCtD
Gabapentin—Oedema—Doxorubicin—thyroid cancer	0.000245	0.000302	CcSEcCtD
Gabapentin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000245	0.000302	CcSEcCtD
Gabapentin—Infection—Doxorubicin—thyroid cancer	0.000244	0.0003	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000241	0.000297	CcSEcCtD
Gabapentin—Shock—Doxorubicin—thyroid cancer	0.000241	0.000297	CcSEcCtD
Gabapentin—Nervous system disorder—Doxorubicin—thyroid cancer	0.00024	0.000296	CcSEcCtD
Gabapentin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00024	0.000296	CcSEcCtD
Gabapentin—Insomnia—Epirubicin—thyroid cancer	0.00024	0.000295	CcSEcCtD
Gabapentin—Tachycardia—Doxorubicin—thyroid cancer	0.000239	0.000295	CcSEcCtD
Gabapentin—Skin disorder—Doxorubicin—thyroid cancer	0.000238	0.000293	CcSEcCtD
Gabapentin—Paraesthesia—Epirubicin—thyroid cancer	0.000238	0.000293	CcSEcCtD
Gabapentin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000237	0.000292	CcSEcCtD
Gabapentin—Dyspnoea—Epirubicin—thyroid cancer	0.000236	0.000291	CcSEcCtD
Gabapentin—Somnolence—Epirubicin—thyroid cancer	0.000236	0.00029	CcSEcCtD
Gabapentin—Anorexia—Doxorubicin—thyroid cancer	0.000234	0.000288	CcSEcCtD
Gabapentin—Dyspepsia—Epirubicin—thyroid cancer	0.000233	0.000287	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CALCB—thyroid cancer	0.000233	0.00562	CbGpPWpGaD
Gabapentin—Decreased appetite—Epirubicin—thyroid cancer	0.00023	0.000284	CcSEcCtD
Gabapentin—Hypotension—Doxorubicin—thyroid cancer	0.000229	0.000282	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000229	0.000282	CcSEcCtD
Gabapentin—Fatigue—Epirubicin—thyroid cancer	0.000228	0.000281	CcSEcCtD
Gabapentin—Pain—Epirubicin—thyroid cancer	0.000227	0.000279	CcSEcCtD
Gabapentin—Constipation—Epirubicin—thyroid cancer	0.000227	0.000279	CcSEcCtD
Gabapentin—BCAT1—Metabolism—SLC5A5—thyroid cancer	0.000224	0.00542	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000223	0.000275	CcSEcCtD
Gabapentin—Insomnia—Doxorubicin—thyroid cancer	0.000222	0.000273	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—TRIM33—thyroid cancer	0.000221	0.00533	CbGpPWpGaD
Gabapentin—Paraesthesia—Doxorubicin—thyroid cancer	0.00022	0.000271	CcSEcCtD
Gabapentin—Dyspnoea—Doxorubicin—thyroid cancer	0.000219	0.000269	CcSEcCtD
Gabapentin—Feeling abnormal—Epirubicin—thyroid cancer	0.000218	0.000269	CcSEcCtD
Gabapentin—Somnolence—Doxorubicin—thyroid cancer	0.000218	0.000268	CcSEcCtD
Gabapentin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000217	0.000267	CcSEcCtD
Gabapentin—Dyspepsia—Doxorubicin—thyroid cancer	0.000216	0.000266	CcSEcCtD
Gabapentin—Decreased appetite—Doxorubicin—thyroid cancer	0.000213	0.000263	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000212	0.000261	CcSEcCtD
Gabapentin—Fatigue—Doxorubicin—thyroid cancer	0.000211	0.00026	CcSEcCtD
Gabapentin—Urticaria—Epirubicin—thyroid cancer	0.00021	0.000259	CcSEcCtD
Gabapentin—Pain—Doxorubicin—thyroid cancer	0.00021	0.000258	CcSEcCtD
Gabapentin—Constipation—Doxorubicin—thyroid cancer	0.00021	0.000258	CcSEcCtD
Gabapentin—Body temperature increased—Epirubicin—thyroid cancer	0.000209	0.000258	CcSEcCtD
Gabapentin—Abdominal pain—Epirubicin—thyroid cancer	0.000209	0.000258	CcSEcCtD
Gabapentin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000202	0.000249	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—TSHR—thyroid cancer	0.000201	0.00485	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.0002	0.000247	CcSEcCtD
Gabapentin—Hypersensitivity—Epirubicin—thyroid cancer	0.000195	0.00024	CcSEcCtD
Gabapentin—Urticaria—Doxorubicin—thyroid cancer	0.000195	0.00024	CcSEcCtD
Gabapentin—Abdominal pain—Doxorubicin—thyroid cancer	0.000194	0.000239	CcSEcCtD
Gabapentin—Body temperature increased—Doxorubicin—thyroid cancer	0.000194	0.000239	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—HRAS—thyroid cancer	0.000194	0.00467	CbGpPWpGaD
Gabapentin—Asthenia—Epirubicin—thyroid cancer	0.00019	0.000234	CcSEcCtD
Gabapentin—BCAT1—Metabolism—RXRA—thyroid cancer	0.000189	0.00455	CbGpPWpGaD
Gabapentin—Pruritus—Epirubicin—thyroid cancer	0.000187	0.000231	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—TSHR—thyroid cancer	0.000182	0.0044	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TPR—thyroid cancer	0.000182	0.00438	CbGpPWpGaD
Gabapentin—Diarrhoea—Epirubicin—thyroid cancer	0.000181	0.000223	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—PTEN—thyroid cancer	0.000181	0.00437	CbGpPWpGaD
Gabapentin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000181	0.000222	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000179	0.00433	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PRKAR1A—thyroid cancer	0.000179	0.00431	CbGpPWpGaD
Gabapentin—Asthenia—Doxorubicin—thyroid cancer	0.000176	0.000217	CcSEcCtD
Gabapentin—Dizziness—Epirubicin—thyroid cancer	0.000175	0.000216	CcSEcCtD
Gabapentin—Pruritus—Doxorubicin—thyroid cancer	0.000173	0.000214	CcSEcCtD
Gabapentin—Vomiting—Epirubicin—thyroid cancer	0.000168	0.000208	CcSEcCtD
Gabapentin—Diarrhoea—Doxorubicin—thyroid cancer	0.000168	0.000207	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000167	0.00404	CbGpPWpGaD
Gabapentin—Rash—Epirubicin—thyroid cancer	0.000167	0.000206	CcSEcCtD
Gabapentin—Dermatitis—Epirubicin—thyroid cancer	0.000167	0.000206	CcSEcCtD
Gabapentin—Headache—Epirubicin—thyroid cancer	0.000166	0.000204	CcSEcCtD
Gabapentin—Dizziness—Doxorubicin—thyroid cancer	0.000162	0.0002	CcSEcCtD
Gabapentin—Nausea—Epirubicin—thyroid cancer	0.000157	0.000194	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—SST—thyroid cancer	0.000156	0.00377	CbGpPWpGaD
Gabapentin—Vomiting—Doxorubicin—thyroid cancer	0.000156	0.000192	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PTCH1—thyroid cancer	0.000155	0.00374	CbGpPWpGaD
Gabapentin—Rash—Doxorubicin—thyroid cancer	0.000155	0.00019	CcSEcCtD
Gabapentin—Dermatitis—Doxorubicin—thyroid cancer	0.000154	0.00019	CcSEcCtD
Gabapentin—Headache—Doxorubicin—thyroid cancer	0.000154	0.000189	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CALCA—thyroid cancer	0.00015	0.00363	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TCF7L1—thyroid cancer	0.000147	0.00355	CbGpPWpGaD
Gabapentin—Nausea—Doxorubicin—thyroid cancer	0.000146	0.000179	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—SST—thyroid cancer	0.000142	0.00342	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CALCA—thyroid cancer	0.000137	0.0033	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC5A5—thyroid cancer	0.000136	0.00328	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—HRAS—thyroid cancer	0.000128	0.0031	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—thyroid cancer	0.000124	0.00299	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CDK1—thyroid cancer	0.000124	0.00298	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARG—thyroid cancer	0.000119	0.00287	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—RXRA—thyroid cancer	0.000114	0.00276	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TSHR—thyroid cancer	0.000108	0.0026	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000106	0.00256	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MEN1—thyroid cancer	0.000101	0.00245	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS2—thyroid cancer	9.36e-05	0.00226	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTCH1—thyroid cancer	9.16e-05	0.00221	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SST—thyroid cancer	8.38e-05	0.00202	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTEN—thyroid cancer	8.17e-05	0.00197	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CALCA—thyroid cancer	8.07e-05	0.00195	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDK1—thyroid cancer	7.3e-05	0.00176	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARG—thyroid cancer	7.21e-05	0.00174	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NRG1—thyroid cancer	5.86e-05	0.00141	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—thyroid cancer	5.67e-05	0.00137	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TERT—thyroid cancer	5.26e-05	0.00127	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIF1A—thyroid cancer	5.03e-05	0.00121	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTEN—thyroid cancer	4.95e-05	0.00119	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—thyroid cancer	4.71e-05	0.00114	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—NRAS—thyroid cancer	4.43e-05	0.00107	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BRAF—thyroid cancer	4.17e-05	0.00101	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KRAS—thyroid cancer	3.82e-05	0.000921	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HRAS—thyroid cancer	3.24e-05	0.000783	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—thyroid cancer	3.15e-05	0.000761	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCND1—thyroid cancer	3.04e-05	0.000734	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTEN—thyroid cancer	2.94e-05	0.000709	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—thyroid cancer	2.86e-05	0.000691	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—thyroid cancer	2.85e-05	0.000688	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NRAS—thyroid cancer	2.62e-05	0.000632	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KRAS—thyroid cancer	2.25e-05	0.000544	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—thyroid cancer	2e-05	0.000484	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HRAS—thyroid cancer	1.92e-05	0.000463	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—thyroid cancer	1.69e-05	0.000408	CbGpPWpGaD
